Increasing evidence suggests that the severe gum disease, periodontitis, may contribute to central nervous system disorders ...

Novo Nordisk’s oral Wegovy gets FDA approval, but rising costs and competition threaten profits. Learn why analysts rate NVO ...

Just before the end of 2025, an oral version of a GLP-1 drug specifically used for weight management moved much closer to ...

The FDA has approved Wegovy (semaglutide) tablets, the first oral GLP-1 receptor agonist for the treatment of obesity.

The FDA has approved the first oral glucagon-like peptide-1 (GLP-1) receptor agonist for weight loss and to reduce the risk ...

The FDA approved the first oral GLP-1 for lowering body weight according to a press release from Novo Nordisk. Oral ...

Scientists are discovering that the oral microbiome—home to hundreds of species of bacteria and fungi—may help predict ...

High levels of the periodontal bacterium Fusobacterium nucleatum may be associated with more severe disability in people with multiple sclerosis.

An oral formulation of semaglutide has received United States Food and Drug Administration approval for a new drug or biologic under the Prescription Drug User Fee Act. The University of Alabama at ...

Abivax (ABVX) stock surged on Obefazimod trial success and takeover rumors. Learn if valuation risks now outweigh reward.

Stage III oral cavity cancer is characterized by larger tumors or lymph node involvement, often diagnosed through physical ...

What Is Oral Lichen Planus? Oral lichen planus is a long-lasting disease that affects your mouth, causing symptoms such as painful white patches, redness, and swelling. It doesn't go away, but you may ...